The report highlights key trends shaping the MedTech industry in 2026. Regulatory pressures and FDA resource constraints may slow approvals, requiring stronger submissions from device manufacturers. At the same time, connected medical devices are driving demand for better data interoperability with EHR systems. Industry consolidation and divestitures are reshaping company portfolios, while growing interest in sleep health, point-of-care diagnostics, and liquid biopsies is expanding innovation opportunities. AI is accelerating the use of real-world evidence for clinical insights and regulatory support. MedTech firms also face a growing battle for tech talent as digital capabilities become central to product development. Strategic partnerships, regulatory harmonization with global quality standards, and rapid advances in surgical robotics are further transforming the competitive landscape.

Join for free to read